HEALTHCARE INDUSTRY ASSOCIATION (HCIA) RESUME BOOK Columbia Healthcare and Pharmaceutical Program

CLASS OF 2018 & 2019 RÉSUMÉS

2018 2019

5 UDIT AGARWAL 14 EHSAN ABBASZADEH 23 HONGBO LIU YAPRAK BARAN MIO ASATANI SAMANTHA MARTIN RAJIV BATRA ELVIS BABILA GABRIEL METZGER

6 SHEFALI BHARDWAJ 15 JOSHUA BARRETT 24 AMANDA NICKLIN TERESA CIACCIO IRINA BENIMOVICH GUS NORTHROP ADAM ESCALANTE MARKENRY BENOIT CAROLINE NOVAS

7 MATTHEW FOXMAN 16 ARI BERG 25 ALEXA PICCIOTTO ALLEN GRANZBERG JIEXIN CAI SAMARA POLLAK JAY NICHOLAS PRANAV CHACHRA SOLOMON RAVICH

8 SONIA KHANCHANDANI 17 ANKIT CHADHA 26 JUSTIN REGGI CHASE KNIGHT VEDIKA CHAWLA HANNAH REITAN SU MAO ANYA CLIFFORD AUSTIN SHAW

9 ALEX MARGOLIS 18 MAOR COHEN 27 SHENGYANG SHI CHRISTINE McLAREN ALEXANDER CZARNOCKI KATIE TSANTES ELIZABETH NYLUND CHRIS DENNEN NAOMI TUDHOPE

10 MILICA PAVLOVIC 19 ALEX ETTINGER 28 SUCHIT TULI ALLISON PERRIN SHAI GAZENFELD CLAUDIA VERDES FENG QIAN SARAH GHOSH JORDAN VIDOR

11 DIVYA RAJ 20 MICHAEL HAHN 29 GOKCE YILDIRIM ADRIENNE ROSENTHAL ZENAH HASAN SHERIE ZHOU NOLAN SARDESAI MORGAN HOLMES

12 ALI I. SECKIN, MD 21 DANIYAL HUSSAIN JASON ZE SU PILSOON HWANG KEITH TABIN NADIA KHOSO

13 MALLORY WEST 22 SEBASTIEN LATAPIE ELLEN YANG JESSIE LAURASH CHEN LI

2 2018-2019 HCIA RÉSUMÉ BOOK HCIA AT COLUMBIA BUSINESS SCHOOL

The Healthcare Industry Association (HCIA) is committed to expanding opportunities outside of the classroom for Columbia Business School students to learn about the many segments of the healthcare industry. Working in close collaboration with the Healthcare and Pharmaceutical Management Program, HCIA organizes a variety of activities throughout the year. It offers members the opportunity to increase their knowledge of the healthcare industry, expand their professional networks, learn about diverse career paths, and secure internships, full-time opportunities, and in-semester projects. The healthcare-related activities broaden students’ exposure to global healthcare practice and complement the learning that occurs in the classroom. Students interact regularly with leading industry practitioners, many of whom are alumni, through experiential learning opportunities and programming. The following events are offered throughout the year: n Columbia Business School Annual Healthcare Conference n Healthcare Career Panel n “Day in the Life” Events with select corporate partners n Lunch and Learn Networking Events n Alumni Networking Events n Executive Speakers n Treks and NYC Site Visits HCIA members accept full-time and internship positions across the spectrum of the healthcare industry. Many students are recruited into management development rotation programs and functional positions (finance, marketing, business development, strategic planning, etc.) at global healthcare enterprises and early-stage life sciences and healthcare services companies. Students also obtain healthcare-focused positions in consulting, investment banking, private equity/venture capital, and nonprofit organizations. More information can be found on our website http://www.columbiahcia.com

3 HEALTHCARE AND PHARMACEUTICAL MANAGEMENT PROGRAM

Columbia Business School’s Healthcare and Pharmaceutical Management (HPM) Program provides students with a real-world understanding of the increasingly complex healthcare environment. Through a multidisciplinary approach shaped by innovative course offerings, complementary out-of-class activities, networking opportunities with industry leaders, and one- on-one career planning/mentoring, the Program offers a dynamic learning experience focused on the major issues affecting the global healthcare ecosystem. The HPM Program emphasizes critical thinking and encourages the development of new approaches to address the strategic, economic, competitive, technological, and sociopolitical challenges facing this important sector. Healthcare courses are offered as electives (no minimum requirements) within the overall curriculum at Columbia Business School, enabling students to tailor their coursework to their individual needs and career aspirations. The HPM Program offers students: n A flexible, comprehensive, and pragmatic array of healthcare courses n A career-focused approach to learning and professional development n A powerful network of alumni and other healthcare business professionals n A global perspective n An entrepreneurial mindset n An attractive New York City location n Access to the world-class Columbia healthcare community The HPM Program was established in 2006. It is currently led by Bunny Ellerin, who brings over 20 years of leadership experience in healthcare to Columbia Business School. Bunny’s diversity of experience includes healthcare delivery, life sciences (pharma and medtech) and digital health, giving her a broad-based knowledge of the entire ecosystem. The Program itself was designed by seasoned industry executives who understand first-hand the skills and industry insight necessary to be successful in this dynamic and highly challenged global business sector. Healthcare electives build on the MBA Program’s rigorous core-curriculum and are designed and taught by a unique mix of experienced industry executives and prominent CBS faculty. They cover each major healthcare sector (biopharmaceuticals, medical devices and diagnostics, healthcare services, and healthcare information technology) on a global basis, from both industry and investor perspectives. Additionally, all functional areas are covered: strategy, management, marketing, finance, business development, M&A, risk management, operations, and policy. The Program helps students successfully pursue careers in pharmaceuticals, biotechnology, medical devices & diagnostics, healthcare services/HCIT, , investment banking, equity research, venture capital, private equity, and entrepreneurship. Information on the HPM Program can be found at: www8.gsb.columbia.edu/healthcare/

4 2018-2019 HCIA RÉSUMÉ BOOK 2018 : Agarwal - Batra

UDIT AGARWAL YAPRAK BARAN RAJIV BATRA [email protected] [email protected] [email protected] Strategy and Marketing Consulting and Marketing Finance and Private Equity

University of Michigan Brown University Indian Institute of Technology Ann Arbor, MI Providence, RI Roorkee, India BSc, Chemical , 2010 BA, Economics, Slavic Studies, 2010 Production & Industrial Engineering, 2009

MEDIDATA SOLNS., New York, NY A.T. KEARNEY, New York, NY ANTARCTICA CAPITAL, New York, NY Corporate Strategy Insights Leader Summer Associate Summer Associate 2017 2017 2017 Mapped global external agency spend Formulated Medidata’s long-term strategy Evaluated private equity investment for leading prestige beauty retailer’s 25+ for the 2018 planning cycle - as part of a opportunities in financial services and brands to identify efficiency opportunities. 4-member Corporate Strategy team. infrastructure. Analyzed agency market landscape and TEMASEK HOLDINGS, , India recommended roster of leading agencies ZS ASSOCIATES, Asia Pacific Associate Director, 2015 - 2016 to enhance client’s creative capabilities. Associate Senior Associate, 2013 - 2015 2016 AMGEN, Dubai, UAE Associate, 2012 - 2013 Market Access Manager Led teams of up to 4 Associates on sales 2015 - 2016 Focus on investment opportunities and marketing consulting projects in the (growth equity and buyout) in healthcare, Formulated account prioritization strategy pharmaceutical industry in Australia, technology and financial services space. Taiwan, Vietnam, Indonesia, Thailand, based on analysis of 120+ accounts for Networked with industry participants China, and India. oncology products. including companies, investment bankers Managed access plans for enlistment and private equity firms to source PwC, New , India in formularies of institutions in GCC proprietary transactions. Consultant countries. Assisted portfolio companies in their 2014 Market Research Manager growth journey and helped them achieve 2014 - 2015 Managed and executed consulting projects operational excellence. in the ports, logistics, railways, shipbuilding, Forecasted revenue of five pipeline and highway sectors in India. products for 2015-2030 to inform MEA AVENDUS CAPITAL, Mumbai, India commercialization strategy. Analyst, Investment Banking, Consumers Vertical ARTHUR D. LITTLE, Boston, MA Facilitated biosimilar entry strategies in 2010 - 2012 Business Analyst region by driving initial assessments and 2011 forecasting. Conducted market research to identify Executed market assessment, commercial Designed and conducted the first Amgen clients and prepared information due diligence and growth strategy projects market research projects in MEA for seven memorandums for M&A/PE transactions. in a range of sectors in the US. therapeutic areas. Built financial models, drove due diligence Partnered with country functional leads to and coordinated deal execution with complete MEA Long Range Sales Plan and lawyers, and investors. Budget 2016. CONSULTING LLP AMGEN, Istanbul, Turkey Mumbai, India Sr. Associate Project Management Business Technology Analyst 2013 - 2014 2009 - 2010 Led cross-functional team to establish Developed and tested data integration regional Liaison Office in Istanbul and tools to integrate various client systems. reduced OPEX by $1m. Developed regional filing, reimbursement, shipment and launch plans for Amgen pipeline.

5 2018 : Bhardwaj - Nicholas

SHEFALI BHARDWAJ TERESA CIACCIO ADAM ESCALANTE [email protected] [email protected] [email protected] Consulting Healthcare Management and Consulting Strategy and Marketing

Boston College Brown University Cornell University Chestnut Hill, Massachusetts Providence, Rhode Island Ithaca, NY BA, Economics and Political Science, 2012 BA, Economics and Italian Studies, 2010 BS, Molecular and Cellular Biology, 2010 ZS ASSOCIATES, San Francisco, CA ALVAREZ & MARSAL, HEALTHCARE PFIZER, New York, NY Associate INDUSTRY GROUP, LLC, New York, NY Summer Associate - Business Model 2015 - 2016 Senior Associate Transformation Advised $10b pharmaceutical company 2014 - 2016 2017 on go-to-market strategy for new product Implemented revised funds flow and Developed go-to-market strategy for launch and on existing product strategy for physician compensation for 1,000+ national launch of a new home delivery HIV portfolio. physicians in School of Medicine. online storefront expected to drive $10m Redesigned complex Incentive in incremental revenue in 2018. Developed process workflows for care in Compensation Awards system to 600+ outpatient management company. ENTERPRISE ANALYSIS CORP. incentivize 2,000 employees at $50b Stamford, CT pharmaceutical company, calculated final Associate Consultant incentive payouts, and generated year-end 2012 - 2014 2014 - 2016 reports for multiple sales teams resulting in Conducted US sales productivity, capacity a demonstrable 20% increase in accuracy Delivered marketing strategy services, and market analysis for med tech company. in incentive compensation payouts. including market segmentation, geographic Created synergy assessment for two opportunity assessments, product launch PwC ADVISORY, San Francisco, CA hospital systems looking to form a optimization, and voice of the customer Senior Associate partnership. analysis to clients in the diagnostics and 2012 - 2015 pharmaceutical industry. Analyst Led clinical trials forecasting workstream 2011 - 2012 Initiated and coordinated campaign and a team of two associates for R&D to uncover synergies between two project with $10b pharmaceutical company; Led Human Resources planning and subsidiaries, with over $1b in annual researched and recommended clinical implementation for major northeast revenues, to maximize value of combined trials forecasting software to streamline hospital merger. intellectual property in oncology existing process and reduce forecasting diagnostics, automation, and genomics. process timeline from 6 months to 3 BELLUCK & FOX, LLP, New York, NY Paralegal months. REGENERON PHARMACEUTICALS 2010 - 2011 Tarrytown, NY Developed future state go-to-market Research Associate I-II strategy across key business functions for Developed companywide protocol for 2010 - 2014 a Top 3 pharmaceutical wholesale. managing responses to the Medicare Secondary Payor Act. Designed and executed experimental Selected as lead analyst for the Health studies to support formulation regulatory Research Institute; assisted in the thought submissions and developed new analytical leadership report development of “Money methods for early stage targets and two Matters: Consumer billing and payment for FDA approved therapies. a New Health Economy”. Led candidate selection strategy for formulation development as part of a cross-functional team that prioritized a single therapy to escalate to human clinical trials.

6 2018-2019 HCIA RÉSUMÉ BOOK MATTHEW FOXMAN ALLEN GRANZBERG JAY NICHOLAS [email protected] [email protected] [email protected] Strategy and Consulting Management Consulting Management and Corporate Development

Northeastern University NYU Stern Boston, MA New Haven, CT New York, NY BS, Business Administration - BA, Ethics, Politics, and Economics, 2013 BS, Economics and Finance, 2009 Finance and MIS, 2011 BAIN & COMPANY, New York, NY SBP MANAGEMENT, New York, NY APTDECO, INC., New York, NY Senior Associate Consultant Senior Analyst Operations Intern, Summer 2017 2013 - 2016 2015 - Present Launched new responsible removal Relevant experience in financial services, Research and diligence healthcare and service, estimated to grow total firm tech, media, healthcare, CPG, and PE technology investment opportunities for a revenue approximately 5%. portfolio companies [Select experience family office investment portfolio. below]. Developed comprehensive strategy to Interface with companies’ management increase positive internet reviews for Reduced complexity of Pharmaceutical and attend investment conferences. business and to establish a baseline for a Co.’s R&D portfolio by refocusing client’s CANACCORD GENUITY, New York, NY net promoter score. strategy from fifteen to five therapeutic Vice President areas. Proposed recommendations to reduce 2014 - 2015 customer service request volume, Led weekly client workshops and working Executed strategic growth initiatives streamline operations, and reduce sessions to help identify high-potential aimed at increasing Leveraged Finance operational costs. assets and M&A opportunities. group’s revenue, participating in over $1b DELOITTE CONSULTING LLP, Redesigned organizational operating of financing transactions across multiple New York, NY model and developed plan for improving industries, reporting directly to the head Senior Consultant, 2015 - 2016 efficiency by ~30% for Finance support of the group. Consultant, 2013 - 2015 function. Worked closely with industry coverage Performed operational analysis to Spearheaded analytical workstream, groups, debt capital markets, research determine feasibility and tax benefits of owning financial model with multiple desks, and the special situations team establishing European services hub that complex and changing client inputs. globally to pitch and structure refinancings, would generate annual tax benefit of growth capital investments, and leveraged Supervised Associate Consultants and ~$300m for a leading U.S. health insurer. recapitalization transactions. help them develop necessary foundational Conducted Deloitte’s 2016 industry skills including model building and client GORDIAN GROUP, New York, NY expense benchmarking study for 16 leading presentations. Senior Associate, 2013 - 2014 providers of group benefits, including Associate, 2011 - 2013 Contributed IP to Bain healthcare practice Aetna, Prudential, MetLife, The Hartford, Analyst, 2009 - 2011 for future proposals and casework on Lincoln, and others. cardiovascular and metabolic therapeutic Founding member of Healthcare Established program governance areas. Restructuring and Structured Finance structures, processes, control frameworks, practices, contributing significantly to their Treasurer of $300k+ office social budget; communications and tools to manage growth. responsible for long-term financial planning 3-year, $29.2m post-merger technology with Office Head and the managing and Led a joint venture team with healthcare integration program for a top 5 global life allocating of the budget. consultants to design turnaround plans for reinsurance carrier. bankrupt Interfaith Medical Center and Reengineered processes for State advise NYDOH and DASNY. government workers’ compensation agency Spearheaded financial analysis supporting to improve timeliness of benefit payments, restructuring of $500b liabilities of Ambac expand access to medical care, and reduce Assurance Corporation and its $4.6b costs for thousands of employers and settlement with 14 banks. healthcare providers.

7 2018 : Khanchandani - Nylund

SONIA KHANCHANDANI CHASE KNIGHT SU MAO [email protected] [email protected] [email protected] Consulting and Entrepreneurship Management and Entrepreneurship Management and Private Equity

Pennsylvania State University, Malvern, PA Cornell University Tsinghua University MS, Finance, 2015 Ithaca, NY Bei Jing, China BS, Applied Economics and Management MS, Biomedical Engineer, 2014 PENN PRESBYTERIAN MEDICAL CENTER, 2009 Philadelphia, PA Nanjing University of Aeronautics Associate MEDIDATA SOLUTIONS, New York, NY and Astronautics 2016 - 2017 Product Marketing Intern Nan Jing, China 2017 BS, Medical Physics, 2007 Achieved zero direct federal citations compared to the market average of 16 by Collaborated with sales, data science, DT CAPITAL PARTNER, Beijing, China developing and implementing innovative and product management teams to create Summer Associate strategies to prepare the hospital staff value proposition, messaging, collateral, 2017 for US Federal Joint Commission’s quality and a Go-To-Market Plan for a new assurance visit. product in the portfolio. Assisted in macro and industry research in healthcare sectors. Led and won hospital’s 2016 organ ABBOTT LABS, Northeast, US donation campaign to raise awareness on District Sales Manager, New York, NY Participated in deal execution. shortage of organ donors in Pennsylvania; 2013 - 2016 HGPT CO. LTD, Beijing, China conducted focus group meetings and District Sales Manager, Baltimore, MD Operations Director community outreach, resulting in 11% 2012 - 2013 2010 - 2016 annual increase in conversion rate of Regional Sales Trainer, New York, NY donations. 2011 - 2012 Made recommendation to support Hospital Sales Specialist, Buffalo, NY company top management decisions by Achieved 27% increased compliance 2010 - 2011 providing insights and advice on medical in patient care planning and pain Internal Pediatric Sales Rep, Columbus, OH device technology. management by training hospital-wide 2009 - 2010 nursing staff to use analytical tools to Managed the service team. monitor compliance with patient records. Promoted to lead 10 sales reps in New Managed the company`s internal staff York City, the company’s largest market, training. PATIKARI POWER PRIVATE LIMITED responsible for 40m in profit annually. , India Supported the key client deals by sales Senior Corporate Compliance and Selected to The President’s Council for strategy planning and communication Governance Officer 2015, which awards the top five percent CHINA DAHENG GROUP, Beijing, China 2008 - 2011 of sales leadership based on market share Sales Manager growth. Ranked #1 or #2 in the U.S. in years Led team of 12 financial analysts and 2008 - 2010 2013-2016. compliance officers to launch a $16m joint Oversaw sales of radiotherapy product in venture for a 4000 MW inter-state power Led a team of seven sales reps in Henan province. transmission system; performed due Baltimore, MD to grow hospital share Developed key market for large-scale diligence and negotiated with stakeholders. eight percent through 10 signed hospital medical devices in Henan province. Project created thousands of jobs in the contracts. states of Sikkim and West Bengal. CHINA DAHENG GROUP, Beijing, China Mentored and developed high potential Researcher Managed a team of four employees on sales rep on the team, leading to 2007 - 2008 legal compliance for $14m, 1320 MW promotion in 2014. thermal power plant project. Facilitated the leading positon of As the Regional Sales Trainer, coached and company`s technological offering with the trained 150+ existing and new-hire sales application of Chinese FDA certification representatives, improving and developing for new products. sales training practices. Developed and supported medical imaging software.

8 2018-2019 HCIA RÉSUMÉ BOOK ALEX MARGOLIS CHRISTINE McLAREN ELIZABETH NYLUND [email protected] [email protected] [email protected] Consulting and Management Pharmaceuticals and Strategy Marketing and Strategy

American University Lehigh University Washington University in St. Louis Washington, DC M.Eng., 2013 St. Louis, MO BA, 2010 BA, Journalism, Science Writing, 2012 BA, Economics, 2011

QUINTILES-IMS, New York, NY OBERLAND CAPITAL, New York, NY GENENTECH, San Francisco, CA Summer Associate Summer Associate MBA Intern, Marketing 2017 2017 2017 Conducted valuations on numerous Analyzed potential target investment Led project to recommend launch multimillion dollar pharmaceutical assets. companies, developed models to structure positioning, objectives and strategies for a investments, and presented opportunities. line extension. Executed due diligences for clients considering asset acquisitions. Assessed early stage deals in the Analyzed market landscape, mapped healthcare industry and recommended patient journey, and conducted scenario GRANT THORNTON, Washington, DC and conducted follow up with target planning to inform recommendation. companies. Senior Associate DELOITTE CONSULTING LLP 2014 - 2016 DELOITTE CONSULTING LLP, New York, NY Conducted provider productivity Philadelphia, PA Senior Consultant, 2015 - 2016 assessment on major national health Consultant Consultant, 2013 - 2015 system. 2013 -2016 Business Analyst, 2011 - 2013 Interviewed hundreds of physicians and Developed corporate and business unit Managed redesign of global organizational hospital directors. level strategies, operating models, and levels for a $10b medical technology processes for life sciences companies. company following a merger; advised , Washington, DC Defined opportunities for health plans 16 business unit leaders on strategy to Senior Consultant to transform their business models and manage changes in their areas. 2011 - 2014 offer resources/tool to providers for care Designed data-driven strategy to assess management and delivery. organizational readiness in preparation for Led change management efforts for a enterprise-wide software implementation major public sector payer organization. ST. LUKE’S UNIVERSITY at a €37b pharmaceutical company. HEALTH SYSTEM, Bethlehem, PA Engaged clients daily to manage public Process Improvement Intern Partnered with C-suite to define relations, strategy, and operations 2013 organizational levels of a $5b hospital decisions. system & health plan; led cross-functional Simulated process improvements to team to develop enterprise-wide enhance efficiency and patient experience communication strategy to implement at an urgent care facility. changes. Presented current state findings and Created dynamic model to assess future state recommendations to urgent compensation program alternatives and care and health system leadership. forecast a multi-million dollar payroll budget for CEO approval at a $2b JOHNSON & JOHNSON, Raritan, NJ academic medical center. Communications Intern Summer 2012, Summer 2011 Analyzed labor spend in eight departments at a $5b academic medical center; Proposed and developed communications collaborated with clinical leaders to plans and news stories, analyzed social identify $3m in annual savings from media practices, and consulted on operational improvement initiatives. improvements to social media. Developed strategy to grow a Deloitte service line’s revenue in the healthcare industry to $23m in four years. 9 2018 : Pavlovic - Sardesai

MILICA PAVLOVIC ALLISON PERRIN FENG (JOHNSON) QIAN [email protected] [email protected] [email protected] Finance and Management Finance and Marketing Strategy and Consulting

University Pompey Fabra Duke University University of Rochester School of Medicine Barcelona, Spain Durham, NC Rochester, NY PhD, 2014 BA, French and European Studies, 2009 PhD, Health Services Research & Policy, 2010 National University of Singapore University of Belgrade CITIBANK, New York, NY Singapore Belgrade, Serbia Summer Associate, Global Cards & MS, Clinical Science, 2005 BS, Molecular Biology, 2008 Consumer Services Shanghai Medical University 2017 Shanghai, China BANK OF AMERICA, New York, NY MBBS, Clinical Medicine, 1998 Summer Associate Developed monthly report templates for 2017 five marketing channels for the American Airlines Cobrands Acquisitions team, giving COLUMBIA UNIVERSITY Created management presentation the team line of sight into the efficiency MEDICAL CENTER, New York, NY pages for two live sell-side transactions in of each channel and facilitating quick Strategic Consulting Intern healthcare dental and IT services industry. decisions regarding budget allocation. 2017 - 2018 Analyzed Canadian biotech company Developed conversational banking Advised strategic alternatives on women’s for IPO opportunity in US market, which implementation strategy for Citi’s FinTech heart project. resulted in recommendation against such team. UNIVERSITY AT ALBANY - SUNY strategy. LASER ANALYTICA, New York, NY Albany, NY MEMORIAL SLOAN KETTERING Senior Manager, 2016 Associate Professor (Tenured) New York, NY Manager, 2013 - 2016 2012 - Present, Assistant Professor Postdoctoral Fellow Senior Analyst, 2012 - 2013 Led two NIH funded R01 grants ($1.75m) to 2016 Analyst, 2011 - 2012 compare effectiveness of coronary stents and Research Associate, 2010 - 2011 Formulated research plan for pancreatic to evaluate hospital risk adjustment metrics. Junior Research Associate, 2009 - 2010 cancer metastasis study and designed Led research work of NYS Cardiac experimental approach over a 3-year Constructed detailed health economic Services Program ($2m/year) and horizon to uncover new treatment options models (cost-effectiveness and budget published 40 papers in peer-reviewed in pancreatic cancer. impact analyses) for specific therapies, medical journals. allowing clients to demonstrate value and NATIONAL CANCER INSTITUTE Led cross-institutional teams on funded subsequently obtain reimbursement for Belgrade, Serbia projects ($1.5m) to use Big Data for their products across many markets. Senior Scientist population health management and to 2015 Served as sole client manager for improve cardiac care for minority groups. numerous engagements; strengthened Designed and led study for 400 breast UNIVERSITY OF ROCHESTER, client partnerships and increased project cancer patients with brain metastasis to Rochester, NY revenue by up to 50% by identifying assess and evaluate tumor biomarkers. Assistant Professor and presenting further opportunities for 2010 - 2012 IRB BARCELONA, Barcelona, Spain collaboration. Led 5 studies from a NIH funded R01 grant PhD Fellow Managed and provided strategic direction ($1M) to assess surgical care quality and 2008 - 2015 for a team of six professionals across outcomes. Discovered diagnostic biomarker for international offices through entire project SHANGHAI FIRST PEOPLE’S HOSPITAL identifying breast cancer patients prone to cycles, including initial planning, research, Shanghai, China develop bone metastasis. model development, report writing, and Cardiac Surgery Resident final deliverables. Co-authored four patent applications used 1998 - 2002 to launch biotech start-up developing Presented research publications at three Performed cardiac surgery, managed commercial tool in cancer diagnostics. international conferences. patients, organized clinical trials.

10 2018-2019 HCIA RÉSUMÉ BOOK DIVYA RAJ ADRIENNE (ISOBEL) NOLAN SARDESAI [email protected] ROSENTHAL [email protected] Strategy and Marketing [email protected] Entrepreneurship and Strategy Management and Technology Columbia Mailman School of Public Health London Business School London, UK New York, New York Icahn School of Medicine MBA, 2018 MPH, 2018 at Mount Sinai Hospital New York, NY University of Southern California MEDIDATA, New York, NY MD, 2019 Los Angeles, CA Product Marketing Intern MS, Biomedical Engineering, 2012 2017 Yale University BS, Biomedical Engineering, 2011 Collaborated cross-functionally with New Haven, CT internal stakeholders to develop Go-To- BA, History, 2012 VASOINNOVATIONS, Los Angeles, CA Market plan for new product estimated at CEO & CoFounder over $7m in potential future revenue. UCLA HEALTH, Los Angeles, CA 2015 Administrative Intern, Operations Coordinated transitional messaging efforts 2017 Co-invented surgical device improving for company’s largest product minimally invasive heart surgery outcomes. Managed and coordinated patient for 65% of annual revenue. Pitched to large corporate partners for outreach following an FDA recall. MARK KRUGER & ASSOCIATES, acquisition/licensing agreements for a New York, NY Worked with various clinical departments $150m market. Pre-MBA Intern on projects including market analysis of Led cross-disciplinary team of seven, 2016 clinical services, creating an advisory board enabling them to deliver business needs structure, and financial analysis. and milestones. Identified and presented engagement opportunities in therapeutic areas VALERA HEALTH, Brooklyn, NY BIONESS, Los Angeles, CA affecting 80k patients; recommendations Intern Associate Product Manager led pharmaceutical company initiatives in 2017 2014 preclinical development. Conducted research on mental health Defined, managed, and executed product Developed strategic insights for pharma systems related to core product, and development and sales strategy activities co entry to rare disease space; generated managed relationship with content vendor. of exoskeletal $21m annual product tactical plan for approaching 50k patients. ARNHOLD GLOBAL portfolio. THE OHIO STATE UNIVERSITY COLLEGE HEALTH INSTITUTE AT MOUNT SINAI Spearheaded innovative marketing OF NURSING, Columbus, OH New York, NY campaign in partnership with sales force; Research Assistant Co-Investigator provided data-centric customer insights 2013 - 2015 2013 - 2016 enabling US sales record of $15m to be achieved. Developed process checklists and Researched effectiveness of alcohol disseminated best practices for $3m self-help group in Saint Vincent and the MEDTRONIC, Los Angeles, CA multisite cancer screening project, Grenadines. Associate Electronics Engineer 2011 enabling streamlined integration of Coordinated in-country approval process communication and research process. for research. Research culminated Led electrical engineering team for Coordinated research efforts of cross- in travelling exhibit, and first author commercialization drug-infusion platform functional team, successfully obtaining $2m publication. by collaborating with global business units in federal funding for behavioral research. and external partners. Performed competitive analysis and engineering due diligence on emerging technologies, presenting insights and recommendations to senior management.

11 2018 : Seckin - Yang

ALI I. SECKIN, MD JASON ZE SU KEITH TABIN [email protected] [email protected] [email protected] Management and Operations Strategy and Marketing Entrepreneurship and Strategy

Istanbul University Medical School Renmin University of China Colgate University Istanbul, Turkey Beijing, China Hamilton, NY MD, 1996 BS, Economics, 2010 BA, History, 2010

Mayo Clinic, Rochester, MN BRISTOL-MYERS SQUIBB, Lawrence, NJ BRIGHT HEALTH, New York, NY Research Fellow Summer Associate Strategy and Business Development Intern 2017 2017 UMDNJ, Newark, NJ Created HCP communication strategy and Led cross-functional ideation around Anesthesiology Residency, patient safety education plan impacting “Bright Spots,” Bright’s centers of care 2000 - 2005 100k patients for leading immune-oncology management and clinical excellence. PD-1 drug Opdivo across seven priority Columbia-Presbyterian Hospital, markets resulting in potentially 20% Constructed model to bring in-house Pain Medicine Fellowship, 2005 decrease in adverse events. the ability to calculate health system reimbursement rates, now used by Bright’s Managed patient advocacy groups and HACKENSACK UNIVERSITY MEDICAL leadership team to inform managed care market research teams to collect key CENTER, Hackensack, NJ contracting. information; built alignments with cross- Vice Chair functional and geographical teams. Institute of Pain and Palliative Medicine PRIVIA HEALTH, Arlington, VA Director of Sales 2005 - Present , Shanghai, China 2014 - 2016 Consultant Created a state of art interventional pain 2013 - 2016 clinic for one of the best 50 hospitals in Constructed market segmentation strategy the US, and the largest healthcare network Designed and launched China’s first and launched market entry for Privia of NJ. specialty drug policy for healthcare reform; Medical Group’s expansion in competitive analyzed customer needs and behaviors Baltimore healthcare market. Prepared protocols and guidelines for the to optimize product design and pricing Led 75+ sales meetings with physician hospital services to improve pain metrics, strategy. which elevated HCAPPS scores. executives, recruiting 52 new providers Successfully launched China’s first across 18 months (175% of goal). Streamlined pain care for Orthopedic and comprehensive health management app THE ADVISORY BOARD COMPANY Neurosurgery Spine service line. for top health insurer; acquired 3m+ active Washington, DC users in seven months. Established economies of scale for Director of Sales and New interventional pain procedures in hospital Analyzed medical provider and patient Product Development based surgical center by decreasing demographic trends to develop go-to- 2013 - 2014 turnover time, automatizing transportation, market strategy for leading Chinese and optimizing room scheduling. insurer; developed comprehensive Spearheaded creation and execution of insurance program to provide service to all sales product launch strategy for business Chosen for “Top Doctor NY Area ” by customer segments (~100m population). intelligence technology still sold today. Castle-Connolly for pain and cancer care. , Health and Benefits, Beijing, China Director of Sales Consultant, 2011 - 2013 2011 - 2014 Analyst, 2010 - 2011 Significantly grew breadth and depth of TD Redesigned healthcare benefits strategies consulting engagements, resulting in over and programs for various Fortune 500 $3.8m in new firm revenue and exceeding companies. annual target. Assessed the launch readiness of US based vision care insurer entering China market.

12 2018-2019 HCIA RÉSUMÉ BOOK MALLORY WEST ELLEN YANG [email protected] [email protected] Marketing and Strategy Venture Capital and Management

Davidson College NYU Stern School of Business Davidson, NC New York, NY BS, Biology, 2010 BS, Finance and International Business, 2012

PFIZER, New York, NY GORE RANGE CAPITAL, New York, NY MBA Summer Associate, Marketing Summer Associate 2017 2017 Led redesign of an unbranded HCP Screened potential investments in health website within a therapeutic area; outlined technology, cosmeceuticals, and oncology strategy, authored new content, and sectors. partnered with cross-functional teams. Created fundraising collateral detailing THE KINETIX GROUP, New York, NY investing strategy, value creation Senior Manager, 2015 - 2016 techniques, and portfolio company case Manager, 2014 - 2015 studies. Senior Associate, 2013 - 2014 Developed sales presentation for Developed new consulting business for a healthcare IT portfolio company for use life sciences company; evaluated market with pharmaceutical and biotechnology opportunity and competitive landscape, customers. outlined compliant business structure, executed pilots, and analyzed data. DELOITTE CONSULTING LLP, Designed patient engagement program New York, NY and drafted strategic messaging to Consultant, 2014 - 2016 increase product penetration and Business Analyst, 2012 - 2014 capitalize on market share for a life Performed merger synergy analysis for sciences company. two national urgent care clinic networks Developed B2B platforms for life sciences and identified over $20m of cost saving companies to generate differential access opportunities through the selection of 64 and increase sales for their customers. clinics for consolidation and restructuring. THE BROOKINGS INSTITUTION Led multidisciplinary teams in identifying Washington, DC and implementing post-merger Research Assistant performance improvement initiatives for 2012 - 2013 seven-hospital system, yielding $15m in Researched payment reform, co-authored annual cost savings for emergency and white papers, and managed strategic operating rooms. relationships with 200+ industry experts Directed 40-member physician leadership to facilitate adoption of new payment and team in assessing integration priorities for delivery models. five-hospital merger in large US metropolis. MEMORIAL SLOAN KETTERING Project managed cross-functional hospital CANCER CENTER, New York, NY teams to plan and execute community Research Technician hospital divestiture and restructuring. 2010 - 2012 Developed product positioning and market Tested novel therapeutic strategies and entry strategy for new surgical equipment analyzed data to treat complications of through conducting focus group interviews hematopoietic stem cell transplants; co- and market research studies. authored 11 journal articles.

13 2019 : Abbaszadeh - Benoit

EHSAN ABBASZADEH MIO ASATANI ELVIS BABILA [email protected] [email protected] [email protected] Private Equity and Entrepreneurship Management and Entrepreneurship Management and Consulting

Northeastern University The University of Tokyo Columbia University Boston, Massachusetts Tokyo, Japan Fu School of Engineering MS, Mechanical Engineering, 2013 LLB, Laws and Political Science, 2013 New York, NY MS, Material Science and Engineering, 2016 Iran University of Science and Technology DELOITTE CONSULTING LLP, Tokyo, Japan Tehran, Iran Life Sciences & Healthcare Sector University of San Diego BS, Mechanical Engineering, 2010 Consultant, 2014 - 2017 San Diego, California Analyst, 2013 - 2014 BA/BS, Mechanical Engineering, 2010 CLEAR BRIDGE, Los Angeles, CA Facilitated discussions with President, Private Equity Intern CATERPILLAR VENTURES, New York, NY Chairman, and executive members on 2017 Operations Manager - product portfolio and M&A strategy Energy, Digital, and Robotics Created deal flow strategy and developed options ($154m M&A deal highlighted in 2016 - 2017 target company strategic valuation criteria, national media). working closely with the founder. Cultivated and maintained relationships Developed multi-channel promotion model with startups and funds in the target Developed and tailored LBO template to for a sales and marketing department that industry. be used in company screening and due led to new project to implement multi- diligence processes moving forward. billion-dollar IT system organizing in-house Led due diligence transactions on potential SIEMENS HEALTHCARE DIAGNOSTICS, sales data. startups. Tarrytown, NY Built annual sales forecasting tool for CATERPILLAR INC. - SOLAR DIVISION New Senior Financial Analyst client’s major drug based on sales data and York, NY 2015 - 2017 market dynamics, and facilitated resource Contracts Manager US North and Canada Managed and improved monthly financial allocation decisions for senior leadership. 2016 closing and planning process for €4b sales Managed project team to implement Led contractual, legal, commercial and P&L. manufacturing operation improvement insurance activities in the Northern Region. Analyzed financial impact of divestiture of of pharmaceutical factory and designed the microbiology business, resulting in 10% training programs for 200+ factory Developed weekly key performance increase in forecasting accuracy. workers. indicator dashboard for billing metrics that evaluated ~$15m/week in revenue for Procurement Specialist Designed and led interviews of sales/ Directors within a privately owned utility 2012 - 2014 marketing department managers of more company. than 20+ Asian-Pacific subsidiaries to Evaluated ROI for hiring additional develop global compliance strategy and CATERPILLAR INC. - SOLAR DIVISION resources to support procurement refine organizational structure. Pittsburgh, PA projects; gained executive management Field Project Manager support in partial outsourcing of Developed strategy for R&D process 2012 - 2016 engineering services, resulting in more acceleration and innovation. than €2m annual savings. Completed a $100m+ project for PEMEX, a Designed CRM model and salesforce Mexican state-owned petroleum company. HARVARD MEDICAL SCHOOL, Boston, MA change management strategies; set target Research Assistant performance and outcome KPIs and Spearheaded an in-house packaging 2011 - 2012 created KPI monitoring scheme. process to minimize the use of packaging materials, that led to $23m annual cost Designed and built a medical device to savings. suppress hand tremors in patients with Parkinson’s disease. Designed and successfully tested the device within the defined timeline, meeting required criteria.

14 2018-2019 HCIA RÉSUMÉ BOOK JOSHUA BARRETT IRINA BENIMOVICH MARKENRY BENOIT [email protected] [email protected] [email protected] Consulting and Management Strategy and Finance Corporate Development and Strategy

Georgetown University School of Medicine New York University The Pennsylvania State University Washington, DC New York, NY University Park, PA MD, 2021 MS, International Business, 2011 BS, Microbiology, 2012

Yale University Baruch College ING CAPITAL LLC, New York, NY New Haven, CT New York, NY Associate - Infrastructure Finance, 2017 BS, Molecular Cellular Developmental BA, International Finance & Pre-Law, 2007 Analyst - Infrastructure Finance, 2014 - 2017 Biology, 2015 Intern - Management, 2013 - 2014 CRÉDIT AGRICOLE CIB, Intern - Structured Export Finance, 2013 STARTUP HEALTH, New York, NY New York, NY Led or co-constructed various credit Summer Fellow Senior Associate, Structured Finance proposals for internal credit and 2016 2014 - 2017 management approval. Consulted healthcare startup companies Structured new transactions and Coordinated internal and external to secure more than $50k of venture monitored a portfolio of $14b. processes for securing financing capital funding. Developed financial models for commitments on new transactions. Coordinated team to evaluate and breakeven analysis and negotiated key Led and coordinated ING’s contribution onboard 20 digital health and medical covenants including reserve accounts, to the $2.85b acquisition financing of device companies into the StartUp Health minimum liquidity, and asset cover the Indiana Toll Road (IJGlobal North portfolio. requirements. American Deal of the Year 2015), one of CENTERS FOR MEDICARE Worked on four restructuring the largest financings ever executed by & MEDICAID SERVICES, Washington, DC transactions in from a $28m Senior Infrastructure Finance-New York team. Secured Facility to a $670m Senior Medical Student Internship Constructed financial models, sensitivity Secured Facility; developed new 2016 - 2017 analyses, and presentation materials strategies for distressed transactions jointly with a Vice President-level team Analyzed insurance plans for essential to avoid Chapter 11 filings and created member for infrastructure advisory work. health benefits on Healthcare.gov, the structures to provide a two-year runway federal health insurance marketplace. utilizing partial debt prepayment. Developed presentations on regional P&L Organized the first annual “Marketplace and budget analysis for internal meetings Issuer Insights & Innovations” conference SUMITOMO MITSUI BANKING with senior management in Amsterdam. CORPORATION, New York, NY for 50+ commercial payers and providers. Compiled and analyzed data from all Associate, Project Finance structured finance teams for budgeting COLUMBIA UNIVERSITY 2011 - 2014 purposes. MEDICAL CENTER, New York, NY Research Fellow Originated, structured, arranged, and Prepared financing proposals and pricing 2017 executed debt financings facilities. analyses for clients. Spearheaded literature review Served as the lead analyst for 18 closed Created loan amortization schedules investigating value-based healthcare transactions and numerous other for approval by relevant export credit models, particularly accountable care potential deals (presented bi-weekly). agencies involved in various transactions. organizations. Maintained a portfolio for closed transactions including amendments, Conducted behavioral economics administration and periodic credit study measuring professional loyalty in reviews; achieved exceptional efficiency relationships between physicians and by executing amendments and patients. applications simultaneously.

15 2019 : Berg - Clifford

ARI BERG JIEXIN CAI PRANAV CHACHRA [email protected] [email protected] [email protected] Entrepreneurship and Management Corporate Development and Private Equity Technology and Entrepreneurship

Columbia University College Fudan University National Institute of Technology of Physicians and Surgeons Shanghai, China Kurukshetra, India New York, NY BA, English and Accounting, 2010 B.Tech, Electrical Engineering and MD, 2019 Computers, 2012 ABBOTT LABORATORIES, Shanghai, China Columbia College of Columbia University Associate Product Manager LYBRATE, Delhi, India New York, NY 2015 - 2017 Group Product Manager, 2017 BA, Biology, 2014 Senior Product Manager, 2016 - 2017 Increased promotional product growth COLUMBIA UNIVERSITY Product Manager, 2015 - 2016 of sales by 69% by adjusting distribution MEDICAL CENTER, New York, NY channel promotion after market analysis. Manager at Series-A funded ($15m) Research Assistant health-tech start-up focused on improving 2013 - 2017 Initiated social media marketing project healthcare access and delivery. Investors and achieved goal of 1000 registrations Performed cost-effectiveness analyses include Tiger Global and Nexus Ventures. for the Center for Hip and Knee six months ahead of schedule with 50% Replacements. budget, championing Best Digital Program Led product team to design, develop in Global Marketing Olympics. and rollout patient-facing web, iOS and Studied the effect of pre-operative Android products serving 3m+ monthly scopolamine administration on post- BOSTON SCIENTIFIC, Shanghai, China users. operative nausea and vomiting and Senior Professional Education Specialist associated outcomes. 2013 - 2015 Facilitated focus groups with sales team Authored a paper on the efficacy of and physicians to strategize product Spearheaded overseas doctor education Aquacel Surgical Dressing in preventing interventions that maximized ROI for SaaS programs by establishing SOP and acute and periprosthetic joint infection. subscribers, increasing renewals by 100% collaboration with 12 host institutions in US and company revenue by 600% in a year. Authored a paper on the trends in and APAC. utilization and outcomes following partial Defined requirements and customized cystectomy in bladder cancer patients. Conducted 15 domestic doctor education products focused on improving patient programs covering 550+ doctors, advancing Shadowed Chairman of Urology and engagement and adherence for three $2b+ clients’ concepts and skills - product usage urological surgeries. Pharma companies. increased by 12 times in one case. COLUMBIA UNIVERSITY ZS ASSOCIATES, Gurgaon, India BIOLOGY DEPARTMENT, New York, NY MEDTRONIC, INC., Shanghai, China Associate Consultant, 2014 - 2015 Summer Undergraduate Research Fellow Clinical Specialist Associate, 2013 - 2014 2013 - 2014 2011 - 2013 Founding member of India & Asia Pacific Performed stem cell research, analyzing Performed analytical troubleshooting and consulting practice area at ZS. the basic characteristics of the epithelial patient treatment consultation through stem cell niche using Drosophila technical support in catheter labs & 8000+ Generated revenue forecast and devised Melanogaster ovaries as a model. patient follow-ups. go-to-market strategy for a blockbuster drug of a Fortune-500 pharma company. MEMORIAL SLOAN-KETTERING MEDTRONIC, INC., Shanghai, China Devised segmentation and marketing CANCER CENTER, New York, NY Business Trainee strategy in diabetes therapeutic area for Research Assistant 2010 - 2011 2010 world’s top selling $42m insulin brand. Built patient referral fast track from Implemented a quality improvement project Co-designed Me2B, a habit building hospital unqualified to implant devices to facilitating the ease with which clinical trials app, and piloted with top pharma firm qualified ones, breaking regulatory barriers were identified and processed. in Vietnam, improving sales by 16% in a for unqualified hospitals to enter market. Assembled and analyzed data for the quarter. Early Onset and Familial Gastric Cancer Registry.

16 2018-2019 HCIA RÉSUMÉ BOOK ANKIT CHADHA VEDIKA CHAWLA ANYA CLIFFORD [email protected] [email protected] [email protected] Private Equity Strategy and Marketing Consulting and Strategy

NYU - Stern Brown University Wellesley College New York, NY Providence, RI Wellesley, MA BS, Finance and Economics, 2012 BSc, Biomedical Engineering, 2013 BA, Bioethics, 2013

WELSH CARSON, New York, NY DELOITTE CONSULTING LLP, SPREZZATURA MANAGEMENT Private Equity Associate Houston, TX CONSULTING, Washington, DC 2015 - 2017 Consultant Business Analyst 2015 - 2017 2015 - 2017 Evaluated investment opportunities in the healthcare and technology sectors through Led a software upgrade for the Led a Congressionally-mandated health IT financial modeling and extensive due emergency room application of a major modernization initiative for Department of diligence. health system client in three geographic Veterans Affairs (VA) client. locations. Created detailed operating forecast Advised VA client leadership on strategies models to determine valuation range and Configured setup for electronic for health IT product management, assess potential improvements under PE submission of a provider’s quality data to organizational development, and financial ownership. comply with a federal mandate and avoid management challenges. ~$10m in 2018 Medicare fee penalties. Served as Board Observer to monitor Created data models to evaluate portfolio companies’ operating and Spearheaded the firm’s inclusion initiative current vs expected health IT software strategic performance. for 55 clinical information systems and personnel costs, informing new VA analysts in the Houston office. contracting strategy which resulted in $4m Executed the $300m sale of Aptuit to annual cost savings for client organization. Evotec by drafting marketing materials and DELOITTE CONSULTING LLP, working with team of advisors. Bangalore, India MANAGEMENT LEADERSHIP FOR TOMORROW, Washington, DC EVERCORE PARTNERS, New York, NY Business Technology Analyst Senior Associate, 2015 M&A Analyst - Healthcare 2013 - 2015 Associate, 2013 - 2015 2012 - 2015 Implemented new functionality in Developed diversity recruiting and Performed financial modeling to evaluate electronic health records of organizations retention strategies and customized various mergers, acquisitions, joint to streamline patient care and integrate solutions, such as events and brand ventures and other transactions. with third-party applications. positioning, for 40+ Fortune 500 Assisted with extensive due diligence and Designed a new template for software companies (e.g., GSK, Google, Goldman worked with senior bankers to develop change control, which was adopted by Sachs). presentations for client board meetings. the client for use by a team of 200+ analysts. Led four division teams in planning and Worked on the ~$13b acquisition of executing quarterly conferences for Omnicare by CVS Health and the $1b sale Founded a weekly email broadcast corporate partners and diverse talent, of Sage Products to Madison Dearborn containing healthcare provider industry encompassing company relationship Partners. updates, which was circulated to 400+ management, communications, and employees. content development. NYU Recruiting Captain and active member of the training team; ranked top bucket all 3 years.

17 2019 : Cohen - Ghosh

MAOR COHEN ALEXANDER CZARNOCKI CHRIS DENNEN [email protected] [email protected] [email protected] Technology and Entrepreneurship Finance and Strategy Entrepreneurship and Finance

University of Michigan University of Illinois at Chicago Yale University Ann Arbor, MI Chicago, IL New Haven, CT BA, Organizational Studies MPH, Health Policy & Administration, 2011 BA, History, 2012 Concentration: Behavioral Economics, 2012 Illinois State University PwC STRATEGY, New York, NY Normal, IL ADVISORY BOARD COMPANY, Manager BS, Biochemistry & Molecular Biology, 2009 Washington, DC 2012 - 2017 Senior Dedicated Analyst, 2015 - 2017 JEFFERIES LLC, New York, NY Advisory Manager within the Heath Senior Analyst, 2014 - 2015 Investment Banking Associate, Not-for-Profit Industries Group in the Management Analyst, 2012 - 2014 Healthcare Consulting practice; helped 20+ clients Developed initiatives to improve 2016 - Present navigate and succeed within the changing organizational culture for health system and challenging healthcare landscape. Execute financing (public/private), M&A clients. and LBO advisory transactions across Advised clients across the healthcare Collaborated with physician leaders not-for-profit healthcare and healthcare industry. Client list includes: large national and HR teams, executed surveys, services sectors. payers, large scale provider organizations, analyzed quantitative and qualitative Supervise and managed multiple analysts cancer hospitals, academic medical data, and presented key findings and during live transactions, pitches, and centers, digital health companies. recommendations to senior executives. internal projects. Promoted to Manager in four years, the Taught communication, project quickest to do so in PwC Advisory. NOMURA SECURITIES, New York, NY management, and data analysis skills to Investment Banking Analyst, Financial groups of up to 200 frontline managers. Institutions Group Launched digital learning product used by 2015 - 2016 20,000 people across 200 organizations. Advised financial institutions within the Designed user interfaces and created asset management, financial technology, content for 35 online leadership and commercial finance sectors on M&A, development courses. strategic advisory, and capital raising. Won firm’s top prize for excellence in Built comprehensive financial models, product and design after developing LBO’s and valued companies using an educational mobile app in company a variety of techniques, including hackathon with 15 other teams. public market comparables, precedent transactions, discounted cash flow, and Built curriculum delivered to 2,500 high- merger analysis. potential rising executives across different sectors of healthcare. BANK OF AMERICA MERRILL LYNCH, New York, NY Conducted primary and secondary Investment Banking Analyst, Healthcare research, created course materials, trained Public Finance faculty, and planned multiday conferences. 2013 - 2015 Executed over $600m of investment financings for not-for-profit hospitals and health systems. Assisted in origination, structuring, and execution of tax-exempt and taxable debt financings and private placements.

18 2018-2019 HCIA RÉSUMÉ BOOK ALEX ETTINGER SHAI GAZENFELD SARAH GHOSH [email protected] [email protected] [email protected] Management and Marketing Marketing Consulting, Strategy, Innovation, Digital Health and Marketing University of Pennsylvania Interdisciplinary Center, Herzliya, Israel Philadelphia, PA BA, Psychology, 2014 University of Chicago BSE, Bioengineering, 2012 Chicago, IL DELOITTE ISRAEL, Tel-Aviv, Israel BA, Economics, 2011 JDS THERAPEUTICS, Purchase, NY Consultant, M&A and Business Product Development Manager, 2016 - 2017 Development Division, Strategy Consulting HAVAS HEALTH, New York, NY Brand Manager, 2015 - 2016 2015 - 2017 Director of Strategy Assistant Brand Manager, 2014 - 2015 2016 - 2017 Conducted industry and market analysis Led cross-functional Product Development to evaluate potential markets for M&A. Provided marketing expertise to Top 5 Team to guide new product investments Pharmaceutical companies on oncology Developed go-to market strategy and based on market research, regulatory brands; utilized customer insights to presented findings to client’s senior pathway evaluation, supply chain and advance key brand imperatives and leadership. manufacturing, and IP analysis. support brand performance. Directed marketing activities for products CHRISTIE’S INTERNATIONAL, Performed patient sub-group analyses RELIZEN® and SERENOLTM, resulting in Tel-Aviv, Israel on both client and competitors’ clinical 141% increase in sales from previous year. Summer Intern trial data to determine target customer 2014 segments and competitive positioning. Coordinated and executed launch of SERENOLTM and correspondingly Administered ongoing office activities, Advised clients on patient experience collaborated with Executive Team to carried out projects in multiple divisions design; collaborated with key physician implement go-to market strategy for including marketing, client relations and leaders to determine new ways to optimize national sales force. administration, to enhance operations the patient experience using digital and client relations. solutions. Reported to CEO, as the Marketing Lead, at a company of over 50 employees during Led client-facing marketing for Christie’s STRATEGY&, New York, NY one year transitional period. Israel event. Pharmaceutical & Life Sciences Senior Consultant SIMON-KUCHER & PARTNERS, Overhauled Israeli client database. 2011 - 2016 New York, NY Advised Top 5 Pharma, Life Sciences, Consultant, 2012 - 2014 PRIME MINISTER’S OFFICE, Tel-Aviv, Israel Assistant to Head of Organization Team and Medical Device Companies on key Delivered actionable recommendations to 2010 - 2011 commercial challenges including product six of the top ten global pharmaceutical launch, expanding into emerging markets, companies across variety of indications Led soldiers team processing intelligence synergy in product portfolios, and M&A including: oncology, neurology, and insights under intense time pressure, restructuring. interventional cardiology, and communicated and presented findings Provided strategic solutions and endocrinology. regularly to senior leadership. developed expertise in biosimilar drugs Created comprehensive commercial Collaborated with cross-functional teams and immunology brands. readiness program for a global to provide ongoing intelligence to head of pharmaceutical company’s lead ovarian organization. UNIVERSITY OF CHICAGO HOSPITALS cancer compound by conducting robust Chicago, IL primary research across the US, EU-5, and Project Associate Japan. 2007 - 2011 Analyzed data for major Family Planning study to determine issues affecting reproductive health and provide crucial information to Planned Parenthood and policy makers.

19 2019 : Hahn - Khoso

MICHAEL HAHN ZENAH HASAN MORGAN HOLMES [email protected] [email protected] [email protected] Private Equity and Consulting Marketing (Pharma/Biotech) Management and Strategy

Carnegie Mellon University Yale University Emory University Pittsburgh, PA New Haven, CT Atlanta, GA BS, Finance, 2013 BA, Economics and International Studies, BA, Economics and Biology, 2014 2011 DELOITTE CONSULTING LLP, TRIAGE CONSULTING GROUP, Atlanta, GA Pittsburgh, PA GUGGENHEIM SECURITIES, New York, NY Senior Associate, 2016 - 2017 Consultant/Business Analyst Vice President, Equity Research Associate, 2014 - 2016 2013 - 2017 2015 - 2017 Led Medicare review process across 250 Performed detailed valuation of three Conducted investment research on 30+ hospital facilities to evaluate transition potential acquisition targets, adding specialty pharmaceutical companies. from ICD-9 to ICD-10 and generated over qualitative considerations that drove the Coverage group included commercialized $8m in revenue for client. acquisition of a community medical center (Market Cap >$1b+) and development-stage Spearheaded comprehensive managed with over $150m in annual revenues. companies (Market Cap <$500m). care and government payment review for a Led multidisciplinary team in reducing Composed over 200 reports from 1-50 complex hospital system and realized over unbilled accounts receivable (healthcare pages in length, covering quarterly $2m in revenue. services company owned by private equity earnings, initiations, disease and Collected data, analyzed hospital payer firm) by $25m through outsourcing the drug-related deep dives, and industry mix and patient population, developed credentialing department and revamped overviews. Analysis was featured in strategy, and conducted payment trend process flows to streamline communication Bloomberg, Wall Street Journal, and analysis to evaluate high risk areas (e.g. between the credentialing department and Barron’s. high cost drugs and new technologies). central billing office. SUSQUEHANNA INTERNATIONAL GROUP, Authored reports delineating hospital Created detailed financial model to value New York, NY revenue cycle issues and presented impact of target platform infrastructure Equity Research Associate comprehensive deliverables outlining data storage delayed availability and led 2013 - 2015 solutions to senior-level leadership. financial discussions with vendor to recoup Pitched investment ideas and industry over ~€100m in lost benefit for the largest Educated hospital billing staff on coding trends for marketing presentations and international outsourcing deal (London issues, updated regulations, and new research reports for 100+ clients, earning based) in the last 10 years. Medicare billing processes to mitigate recognition from Institutional Investor as future cash loss. Identified over $25m in synergies “Rising Star” in Specialty Pharmaceuticals. associated with the merger of two large Enhanced project workflow processes Incorporated scenario analysis of academic medical centers through across multiple internal departments to changes in pricing environment, new improved pricing for physician preference achieve faster revenue generation for entrants, acquisitions, pipeline successes/ items and commodities, consolidated back- client. failures, and regulatory developments office support, and increased referrals when building financial models for ~20 from physicians to hospitals, etc. Trained seven associate consultants in companies. data analysis, contract modeling, and client service. ROYAL BANK OF SCOTLAND, Stamford, CT Investment Banking Analyst 2011 - 2013 Developed complex merger model for an industrial gases company evaluating debt rating impact of various acquisitions. Presented transaction options to CFO, earning $2b acquisition funding deal.

20 2018-2019 HCIA RÉSUMÉ BOOK DANIYAL HUSSAIN PILSOON HWANG NADIA KHOSO [email protected] [email protected] [email protected] Venture Capital and Private Equity Finance Healthcare

Columbia University Yonsei University Georgetown University New York, NY Seoul, South Korea Washington, DC MPH, 2015 BA, Business Administration 2013 BA, International Relations and Spanish Language and Literature, 2011 University of Pennsylvania NH INVESTMENT & SECURITIES Philadelphia, PA Seoul, South Korea ELI LILLY & COMPANY, Dubai, UAE BSc, Chemical & Biomolecular Engineering, Investment Banking Associate Senior Medical Representative 2009 2015 - 2017 2016 - 2017 BA, Economics, 2009 Underwrote four IPOs on Korean stock Managed pre-launch activities for ASTRAZENECA, Gaithersburg, MD exchanges; focused on healthcare psoriasis product in the Gulf, with Associate Director - ImmunoOncology companies regional launches in 2017. 2016 - 2017 Conducted due-diligence on finance, Led a segmentation and targeting Developed commercial launch strategies company structure, and business plans exercise of physicians following thought for novel oncology assets. to identify and resolve potential issues leader identification and mapping. in IPO Led forecasting process and conducted Mapped the patient journey exercise customized market research to identify Spearheaded drafting of offering for the auto-immune portfolio to gauge commercial value drivers for Bladder and prospectuses and listing-related patient flow. Head & Neck cancer drugs. documentations for stock exchanges and regulators AMGEN, Dubai, UAE Conducted commercial assessments to Regional MEA Pipeline Product Manager guide strategic investment decisions across Built financial models to value companies; 2014 - 2016 various solid tumors. executed sales and marketing strategies for initial offerings. Managed two blockbuster pipeline Implemented a >$1m process for tracking products in cardiology and immunology; post launch drug performance. PwC, Seoul, South Korea responsible for market rollouts in 17 Senior Audit Associate, 2013 - 2015 HURON CONSULTING, New York, NY Middle Eastern/African countries, Audit Associate, 2011 - 2013 Manager including sales team training and regional 2014 - 2016 Performed statutory audits as in-charge brand strategy. auditor or sub-team leader in team of Led strategy engagements across life- Spearheaded commercial efforts and five or more staffs in various industries, science clients spanning the entire clinical coordinated inter-functional alignment and completed auditor’s reports of both development spectrum across various across several teams - including Medical, separate and consolidated financial diseases. Supply Chain, and Pricing - to maximize statements based on IFRS and US GAAP product performance and streamline Evaluated and developed detailed Collected data from dealer networks, operations post-launch. business cases around acquisition targets. analyzed KPIs, and delivered quarterly Secured key partnerships with leading Utilized multi-attribute decision tools to analyses and presentations to CEO and cardiology associations through disease identify high priority therapeutic areas. Board of a German automotive company education campaigns, positioning Amgen on financial and operational performance as a leader in the growing cardiovascular FRANKEL GROUP, New York, NY field. Consultant Led tax adjustment tasks and special 2009 - 2013 audit projects for companies in Kaesong Organized product training program and Industrial Complex, North Korea materials for a regional workshop. Developed commercialization, business development, pricing and life cycle strategies for life-science clients.

21 2019 : Latapie - Metzger

SEBASTIEN LATAPIE JESSIE LAURASH CHEN LI [email protected] [email protected] [email protected] Venture Capital Strategy and Management Consulting and Strategy

McGill University, Montreal, Quebec, Canada Georgetown University New York University MSc, Biochemistry, 2012 Washington, DC New York, NY BS, Biology - Global Health, 2011 MS, 2012 NEW MARKETS ADVISORS, Boston, MA Manager, 2016 - 2017 MEDIQUIRE, New York, NY Sichuan University Associate, 2013 - 2015 Director of Operations Sichuan, China 2016 - 2017 BS, 2010 Shortlisted 8 startups to advance US digital health presence of German-based global Developed initial operating model FROST & SULLIVAN, Shanghai, China pharmaceutical company by evaluating 231 across cross functional teams, as well as Senior Consultant, 2016 - 2017 companies, attending 8 industry events, corporate key performance indicators to Analyst, 2015 - 2016 and interviewing 45 entrepreneurs across track and report on company growth. the country. Executed strategic engagements in Managed product delivery, client biotech, pharmaceutical, med-tech and Led three-person team to design “Beyond satisfaction, and same store growth healthcare service sectors. the Pill” strategy for oncology division of a opportunities for all health center $16b+ in revenue pharmaceutical company partners. Created deliverables to support strategic with recommendation to create a patient- and investment decisions based on market Created new pricing model and client engagement mobile app for Germany, trends, unmet needs, and competitive contract for core population health Japan, and US implemented. landscapes. technology product. Developed launch strategy and tiered Recipient of Excellence Performance service offering for novel heart failure EVOLENT HEALTH, Arlington, VA Award in two consecutive years, resulting device of a global medical device Associate Director in a fast-track promotion. company by attending industry events and 2014 - 2016 interviewing physicians and patients. COLUMBIA UNIVERSITY Identified and analyzed opportunities to MEDICAL CENTER, New York, NY partner with leading health systems in the GOODMAN CANCER CENTER, Lab Manager value-based healthcare space. McGILL UNIVERISTY, Montreal, QC 2012 - 2014 Researcher Developed business plans for Medicaid Oversaw financial management for lab 2010 - 2012 and Practice Optimization service funding, including budgeting, accounting, offerings. Advanced characterization of a novel and negotiating supply prices with 20+ protein involved in kidney cancer by Supported the design of a state-wide suppliers. designing experiments and communicating Medicaid health plan for the Mississippi Designed and developed novel mouse key results to supervisors and academic Hospital Association. models using gene-targeting techniques for peers. studying different types of tumorgenesis. BOOZ ALLEN HAMILTON, Washington, DC Senior Consultant 2011 - 2014 Provided project management support to the Department of Health and Human Services and its implementation of the health insurance exchange program.

22 2018-2019 HCIA RÉSUMÉ BOOK HONGBO (BO) LIU SAMANTHA MARTIN GABRIEL METZGER [email protected] [email protected] [email protected] Private Equity and Strategy Technology and Private Equity Corporate Development and Management

Emory University Georgetown University Columbia University Atlanta, Georgia Washington, DC New York, NY BA, Chemistry and Economics, 2013 BS, Human Science, 2013 BA, Political Science; Special Concentration in Business Management, 2013 , New York, NY DELOITTE CONSULTING LLP Engagement Manager, 2016 - 2017 New York, NY PwC, New York, NY Associate, 2015 - 2016 Consultant, US Strategy, 2015 - 2017 2016 - 2017 Senior Consultant, 2014 - 2015 Business Analyst, US Strategy, 2013 - 2015 Designed risk management and regulatory Consultant, 2013 - 2014 Developed future revenue opportunity reporting strategies for five global banking Promoted every review cycle directly model to estimate clients’ professional institutions through rigorous evaluation of to post-MBA position and recognized services spend, identified $300m existing systems and provision of subject amongst top performers in starting class incremental opportunity across Deloitte’s matter expertise to enhance processes every year. core and adjacent markets. moving forward. Managed teams of ~four direct reports Partnered with data analytics start-ups to Managed project timeline/priorities along and led project execution, analytics, build cognitive technology-powered risk with workload of other junior staff and and communications with senior client assessment platform for financial services produced comprehensive deliverable on executives. clients, developed use cases for testing time and under budget as part of thorough hypotheses on novel datasets. reporting system analysis. Engaged with internal and client senior leadership teams to spearhead key growth Created business cases for US Executive WELLS FARGO, New York, NY initiatives, including design of organization Committee recommending $10m+ Credit Analyst, 2015 - 2016 structure for a late-stage healthcare investments in three of six proposed Financial Analyst, 2013 - 2015 company as part of its overall IPO high-growth industries, resulting in 30% readiness strategy. increase of projected annual revenues Collaborated closely with internal product by 2020. partners and client’s management team MERCK & CO, Rahway, NJ to execute underwriting of bank loan Intern GEORGETOWN UNIVERSITY financings from origination through closing. 2011 MEDICAL CENTER, Washington, DC Formulated credit models and developed Undergraduate Research Fellow Collaborated with cross-functional presentations evaluating key structural/ 2012 - 2013 research teams to identify candidates for financial issues for approval discussions early stage cardiovascular drug-discovery Conducted research on treatment for with senior loan officers. pipelines. pediatric brain cancer exploring potential Led analyst group in preparing detailed correlation with hormone exposure, Presented findings with potential patent credit approval memos for transactions demonstrated marked differences considerations at project meetings to and coordinated the office’s overall credit in tumor growth following various departmental and R&D senior leadership. processes and reporting requirements. treatments. Co-authored two publications in medical journals Oncotarget (2013) and Oncogene (2014), presented findings to senior faculty in the Georgetown University Department of Human Science.

23 2019 : Nicklin - Ravich

AMANDA NICKLIN GUS NORTHROP CAROLINE NOVAS [email protected] [email protected] [email protected] Marketing and Management Marketing and Strategy Marketing and Strategy

Cornell University College Oxford University Hamilton College of Veterinary Medicine Oxford, UK Clinton, NY Ithaca, NY BA Medical Sciences, 2011 BA, Political Science, 2013 DVM, 2014 GLOBE LIFE SCIENCES, London, UK DELOITTE CONSULTING LLP, Arlington, VA Rensselaer Polytechnic Institute Consultant, 2017 Business Consultant - Federal Health Troy, NY Promoted to most senior non-partner 2014 - 2017 BS, Biology, 2010 grade within Globe (shortly before Designed and delivered in-person and departing for MBA). virtual acquisition and budget training PUNCH FASHIONS, New York, NY to 400+ full-time employees at the Food Production Manager, 2017 Senior Analyst, 2014 - 2017 and Drug Administration; worked closely Business Analyst, 2016 - 2017 Led ‘war-gaming’ workshop with cross- with senior acquisition, finance and IT functional executives at top 10 pharma to Negotiated product costing with factory to professionals to develop FDA specific modify $370m brand’s strategy prior to ensure 40% gross margin and to meet legal systems based acquisition training. and company quality requirements. competitor launch, contributing to repeat business (annualization of this strategic Led management approaches for over Directed sales, production, and warehouse exercise). six multimillion dollar federal healthcare teams in transition of 25 new accounts to Modeled biotech’s entire pipeline ($500m proposals, including staff requirements, new software system and warehouse. rNPV) for C-suite management, with chain of command, quality control and IT valuation underpinning 3 major pharma security approaches. ANIMAL EYE GUYS, Fort Lauderdale, FL collaborations ($200m upfront, >$5b Led implementation of new human Ophthalmology Specialty Intern potential milestones). resources system at 15 VA hospitals to 2015 - 2016 Managed review of diagnostic company’s ensure accuracy of personnel records; Examined and developed appropriate R&D strategy, resulting in changes to the consulted with hospital executives, diagnostic and therapeutic plan for R&D strategy and CEO. executed internal assessment, developed approximately 30 patients per day. new SoPs and executed staff training. Business Analyst, 2013 - 2014 Led revision of medical templates Designed and delivered quarterly HILL+KNOWLTON STRATEGIES to increase doctor efficiency and competitive intelligence reports for $750m Santa Monica, CA comprehensiveness of medical records. franchise at top 10 pharma, leading to Healthcare Public Relations Assistant project renewal and top consultancy 2013 - 2014 ANIMAL MEDICAL CENTER, New York, NY ranking in 2014. Small Animal Medicine Developed growth strategies and account Completed market and product assessment and Surgery Rotating Intern plans for biopharmaceutical and medical of biotech’s lead Phase II program, with 2014 - 2015 device clients (Amgen, Halozyme, the forecast underpinning negotiations McKesson and Cerus). Prioritized care of most critically ill in subsequent $650m acquisition ($200m patients and delegated treatments to upfront) by major pharma. Drafted press releases, pitches, facilitate rapid flow through emergency backgrounders and developed media lists Research Analyst, 2012 - 2013 room. and coverage reports. Received fast-track promotion to Business Collaborated with and presented cases to Analyst (<1 year). more than 60 board-certified specialists and residents in care of hospitalized IMS HEALTH, London, UK patients. Analyst Intern, 2011 - 2012 Provided analysis for oncology projects during 3-month internship (permanent job offer secured).

24 2018-2019 HCIA RÉSUMÉ BOOK ALEXA PICCIOTTO SAMARA POLLAK SOLOMON RAVICH [email protected] [email protected] [email protected] Strategy and Operations Strategy and Technology Strategy and Management

University of Maryland George Washington University University of Michigan - College Park, MD Washington, DC Ross School of Business BS, 2013 BBA, Finance, 2013 Ann Arbor, MI BBA, Strategy, 2012 MINDSHARE, New York, NY DELOITTE CONSULTING LLP, Supervisor New York, NY BIOMEDICAL INFORMATICS AT 2016 - 2017 Consultant, 2015 - 2017 COLUMBIA UNIVERSITY MEDICAL Business Analyst, 2013 - 2015 (HI-FIVE), New York, NY Prepared weekly competitive landscape Strategy Consultant update of the personal care category that Analyzed data from 15 design sessions 2017 focused on promotional mix financials to provide strategic recommendations and social listening analysis that informed on global stakeholder engagement, Developed growth strategy for health media strategies. communications, and training requirements informatics training programs designed for healthcare organization’s process for provider professionals including 200+ Launched multiple campaigns, including redesign resulting in savings of $1.8b. medical doctors and nurse practitioners. Dove Dermacare anti-dandruff shampoo, Dove Men + Care, and Suave Developed employee engagement strategy GOLDMAN SACHS, New York, NY Professionals. for firm-wide technology migration at a Management & Client Strategy health insurance company. Led cross- Amassed comprehensive data on 2014 - 2017 functional team of 15 change agents consumer market, developed go-to- and disseminated key information to all Designed and led market share growth market strategy, and collaborated with organization business units. initiative across 500+ sales members, inter-agency teams to prepare and conducting competitive analysis and client execute launch timelines. Conducted data analysis for claims and segmentation to identify potential revenue benefits software implementation and of $150m+ over three years. Senior Associate delivered recommendations to program 2014 - 2016 leadership to target key management Led team of six across Sales, Legal, and improvement areas. Technology to design commercialization Created a new method of tracking strategy, resulting in $3m+ revenue growth. budget transactions to improve clarity Designed change management strategy and transparency, enabling both internal to streamline global R&D operations for Conducted study of 25+ investment firms and client teams to monitor changes Fortune 50 health and pharmaceuticals to develop accountability framework to across budgets up to $30m quickly and company to target $400m in cost savings. respond to client feedback, generating accurately. $2m+ growth in sales revenue. Supervised production of 100 unique Managed a six-member team feasibility technology training manuals in one month PwC ADVISORY, New York, NY study to determine the opportunity to to aid system adoption for 48k users. Senior Associate Consultant advertise to a new segment of credit card Conceived analytics tool for web system 2012 - 2014 prospects for American Express. focused on identifying and improving Directed team of three consultants and six operational inefficiencies. developers as project testing lead for sales Performed spending analysis for Federal and trading software, resulting in improved practice by identifying peak spending throughput rates. drivers. Information used to equip Trained 30+ clients on IT procedures, leadership with messaging priorities; leveraging client insights and industry resulted in $300k in company savings. leading metrics to strengthen cyber security, resulting in cost savings of $10m. Awarded “Rookie of the Year” honors for outstanding client service.

25 2019 : Reggi - Tudhope

JUSTIN REGGI HANNAH REITAN AUSTIN SHAW [email protected] [email protected] [email protected] Entrepreneurship and Strategy Marketing and Strategy Marketing and Strategy

University of Pennsylvania University of Michigan Columbia Mailman School of Public Health Philadelphia, PA Ann Arbor, MI New York, NY BA, Biological Basis of Behavior, 2012 BA, History and International Studies, 2013 MPH, 2019

BLUEPRINT RESEARCH GROUP, DELOITTE CONSULTING LLP, Chicago, IL University of North Carolina at Chapel Hill New York, NY Consultant, 2016 - 2017 Chapel Hill, NC Senior Consultant Business Analyst, 2014 - 2016 BA, Economics, 2013 2012 - 2017 Created strategic vision for Fortune HOSPITAL FOR SPECIAL SURGERY, Opened London office with Associate 100 pharmaceutical company’s contract New York, NY Partner through management of EU-based manufacturing business; conducted Pre-MBA Strategy Intern projects, pitching and winning ~$5m of executive interviews, launched and 2017 work in 2016 (main clients: Roche, Amgen, analyzed an employee survey, and & AstraZeneca). presented findings to senior leadership. Developed dynamic dashboards for C-Suite to analyze regional markets, Refined $50b client’s understanding Managed design of post-close global patient geography, and competitive market of relapsing remitting and primary operating model for medical device share. progressive multiple sclerosis markets to company $500m joint venture; worked inform launch strategy for new product; with VP-level clients to create operational Guided discussions with Senior VPs and led workshop in Switzerland for audience process flows, draft contract schedules, physicians to determine desired outputs of >40 international stakeholders. and prepare staff for organizational for dashboards. changes. Guided client’s portfolio strategy by DELOITTE CONSULTING LLP, McLean, VA quantifying opportunity across diabetes, Partnered with commercial leadership of Strategy & Operations Consultant chronic kidney disease, and chronic heart $150m orthopedic implant company to 2015 - 2017 failure, ultimately recommending co- manage post-acquisition growth initiative Worked across provider space to conduct positioning approach to mitigate cross- to recruit 30 top sales representatives; outpatient and competitive analysis and product cannibalization. presented progress weekly to President, build financial models for C-suite clients to forecasted inventory needs for new hires, Reviewed company performance, monitor implementation of newly adopted and tracked sales metrics. established growth targets, and created strategic initiatives. and directed internal initiatives as the Analyzed customer data sets for a $24m Led teams of data scientists, designers, most junior member of leadership product line integration; identified 1,500 and developers to apply design thinking team; company growth from 2012-2016: new customers, built model to monitor and transform big data into user-friendly $12m-$40m revenue, 15-80+ employees, 1-5 account-specific sales, and helped client prototypes for multiple clients through a offices. prioritize field force outreach to exceed Deloitte Analytics Fellowship. goal of retaining 70% of pre-close revenue. Founded pro bono arm of company by DELOITTE CONSULTING LLP, McLean, VA spearheading first-ever partnership with ACCESS COMMUNITY Strategy & Operations Business Analyst a non-profit (Solving Kids’ Cancer) in 2016 HEALTH NETWORK, Chicago, IL 2013 - 2015 and creating internal committee that Temporary Project Manager initiated relationships with three more Established global reporting processes to 2013 healthcare non-profits in 2017. track execution of new finance activities Created reports on clinical data at 30+ across all locations globally for two major Influenced senior leadership to partner primary care clinics, analyzing trends in pharmaceutical companies. with data analysis and visualization startup; provider productivity, patient-visit cycle collaboration reduced project time Operationalized an SAP Center of time, and appointment no-show rates. dedicated to analysis and client follow-up Excellence for major utility company, and by ~30%. created automated metrics dashboards to track organization performance.

26 2018-2019 HCIA RÉSUMÉ BOOK SHENGYANG SHI KATIE TSANTES NAOMI TUDHOPE [email protected] [email protected] [email protected] Private Equity Social Enterprise and Management Consulting and Strategy

The University of Hong Kong Boston College Wesleyan University Hong Kong, China Chestnut Hill, MA Middletown, CT BSc (Quantitative Finance), 2012 BA, Political Science and Islamic Civilization BA, East Asian Studies, 2011 2013 BARING PRIVATE EQUITY BRUNSWICK GROUP, Shanghai, China ASIA, Hong Kong DELOITTE CONSULTING LLP, Boston, MA Account Director, 2016 - 2017 Investment Associate Consultant Executive, 2015 - 2016 2015 - 2017 2013 - 2017 Developed and implemented Screened and researched investment Developed roadmap to automate profit comprehensive communication and opportunities across Greater China. reviews for global biopharmaceutical stakeholder engagement strategies corporation to enable policy for clients on critical issues affecting Deal execution and portfolio implementation and local tax compliance reputation and valuation. management (Rici Healthcare, a leading in 70 countries. Chinese private hospital and medical Advised management of leading check-up centers; Cath Kidston, a UK Managed global data reconciliation effort pharmaceutical and medical device fashion brand; and Solera Holdings, a across three continents to facilitate companies during and following US-based global auto insurance software transfer pricing center of excellence go- government investigations. company) live. EMERGING STRATEGY, Shanghai, China Led data analysis supporting first UBS, Hong Kong Consultant successful open enrollment period for Associate Director 2014 state health exchange. 2013 - 2015 Oversaw the company’s largest Designed board of directors report for Advised companies’ capital markets and engagement: global market assessment for state health exchange to track member M&A transactions in technology, media a leading educational testing company. population behavior and improve health and telecom sectors. outcomes over time. Managed six-person team and delivered twice monthly reports to client. BARCLAYS, Hong Kong Led customer engagement workstream Analyst as part of a pilot market Affordable Care GBI, Shanghai, China 2012 - 2013 Act strategic refresh for global health Content Marketing and Corporate services organization; created innovative Worked on LBO and leveraged finance Communications Specialist ‘Community of Health’ solution while transactions. 2013 - 2014 introducing and transitioning interactive geographic Tableau model to client team. Spearheaded GBI’s marketing strategy for growing product portfolio of pharmaceutical industry intelligence, resulting in sales 25% above target.

PFIZER, New York NY International Public Affairs Research Consultant 2011 - 2012 Analyzed policy risks and opportunities and developed strategic communications to support business priorities.

27 2019 : Tuli - Zhou

SUCHIT TULI CLAUDIA VERDES JORDAN VIDOR [email protected] [email protected] [email protected] Venture Capital and Entrepreneurship Marketing Strategy and Consulting

University of Delaware University of Navarra Rutgers University Newark, DE Pamplona, Spain New Brunswick, NJ Honors BS, Finance, 2012 BS, Chemistry, 2012 BA, Political Science, Media Studies, 2009 Honors BA, Biology, 2012 CRESENS DERMOCOSMETICA ANTHEM, INC, New York, NY METAPROP NYC, New York, NY Guayaquil, Ecuador Director, Sales & Strategy Venture Fellow Director, Research and 2017 - Present 2017 Development and Operations Lead and oversee Empire Blue Cross Blue 2015 - 2017 Conducted end-to-end diligence on early Shield’s Small Group business segment stage startups, resulting in multiple $100k+ Led creation, development and Accountable for strategic growth initiatives investments. manufacturing of a new skin care line of and long-term planning within Empire’s high efficacy products. Identified potential strategic LPs and commercial group business department created pitch materials for raising a $25m+ Delivered presentation at the 21st Manager, Sales fund. Ecuadorian Congress of Dermatology 2016 - 2017 to 500+ dermatologists and cosmetic RUBICONMD, New York, NY surgeons, raising brand awareness. Designed the Small Group market re- Ops and Implementation Manager launch strategy for Empire Trained medical representatives on the 2016 - 2017 mechanisms of action of active ingredients. Executed on the re-launch plan and led Spearheaded projects to enhance provider Empire back to profitability in the Small utilization of service and lower platform QUIMIBIOS, Barcelona, Spain Group segment for the first time since operations time. Sales and Marketing Manager 2007 2014 - 2015 Refined go-to-market strategy for Senior Business Development Specialist correctional institutions and clinician Achieved 12% increase of projected sales 2015 - 2016 onboarding for all customers. of raw materials for 2015 by renegotiating terms with key client accounts. Developed growth initiatives in support of growing Empire’s Individual/ACA market THE ADVISORY BOARD COMPANY, Developed new presentation materials share Washington, DC for the company’s portfolio of active Product Strategy Senior Analyst ingredients resulting in the addition of Advised department heads on growth 2014 - 2015 three new clients from the pharmaceutical opportunities across the various industry. Developed new products to resolve commercial segments industry-wide issues and tested them Expanded business to Portugal, delivering Marketing Research Analyst among healthcare executives. database of 20 potential new clients and 2013 - 2015 establishing first contact. Improved value proposition of existing Researched competitive trends in support products and formed strategic alliances in MARTIDERM, Cervello, Spain of Empire’s launch into the Individual/ACA and outside firm to drive revenue growth. Marketing Assistant markets 2013 - 2014 JPMORGAN CHASE, New York, NY Launched a successful retail sales strategy Corporate Development Analysts Liaised between R&D and Marketing to distribute the company’s direct-pay 2012 - 2014 departments, improving content of medical products brochures, training material and product Reduced firmwide expenses, improved packaging, resulting in higher brand global operations, and identified efficiency approval by dermatologists. opportunities as part of a rotational Collaborated in creation of new brand program. image, coordinating design of new packaging for all existing products.

28 2018-2019 HCIA RÉSUMÉ BOOK GOKCE (GILLY) YILDIRIM SHERIE ZHOU [email protected] [email protected] Private Equity and Strategy Strategy and Consulting

Columbia University University of Virginia New York, NY Charlottesville, VA MSc. Biomedical Engineering, 2004 BS, Biology, 2014

New Jersey Institute of Technology NSF HEALTH SCIENCES, Washington, DC Newark, NJ Associate Practice Manager BS. Industrial Engineering, 2003 2017 Drove client engagements by developing STRYKER, Mahwah, NJ proposals and budgets, forecasting Staff Product Development Engineer costs, negotiating contracts with VPs 2013 - Present and Directors, and created supplemental Assessed the feasibility and valuation documents to help clients obtain project of new products and technological approvals from the C-suite. platforms for business and customer needs. Pitched and secured $2.1m engagement with a Private Medical Devices Company: Advised business development on the Led team of eight quality engineer cost of M&A versus internal development consultants and identified 100+ significant for portfolio needs. compliance gaps across all manufacturing Generated and pitched intellectual systems and implemented strategies to property ideas for next generation improve the reliability of four products robotic and additive manufacturing and thus reduce product recall; secured technologies to the executive leadership. additional $7m proposal for subsequent phase of work. PIPELINE ORTHOPAEDICS, Cedar Knolls, NJ NSF HEALTH SCIENCES, Washington, DC Research Engineer Research Associate 2011 - 2013 2014 - 2017 Tested orthopedic implants and Achieved FDA approvals for five medical generated regulatory reports for FDA devices that diagnose and/or manage pain, clearance of 10 devices. hearing loss, heart attacks, and diabetes. Generated research and marketing materials for scientific conferences and Led strategic planning presentation to publications. firm’s senior management, focusing on industry trends, lead generation, and NYU LANGONE CENTER, New York, NY proposal success rates. Research and Development Engineer Suggested increased thought leadership 2004 - 2011 resulting in 133% more leads for Lead a team of engineers, surgeons, and combination product support (2015 to 2017 interns on orthopedic pre-clinical tests. YTD). Collaborated with major orthopedic companies to address their research and develop0ment needs. Authored NIH research grants and IRB approvals for patient studies. Presented findings in major conferences and publications.

29 NOTES

30 2018-2019 HCIA RÉSUMÉ BOOK 31 Healthcare & Pharmaceutical Management Program www8.gsb.columbia.edu/healthcare

Healthcare Industry Association (HCIA) columbiahcia.com

32 2018-2019 HCIA RÉSUMÉ BOOK